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Autoregulation of collagenase production by a protein synthesized
and secreted by synovial fibroblasts: Cellular mechanism for
control of collagen degradation
(phorbol myristate acetate/connective tissue regulation/immunoprecipitation)
CONSTANCE E. BRINCKERHOFF*t, MARY C. BENOIT*t, AND WILLIAM J. CULPt
Departments of *Medicine and tBiochemistry, Dartmouth Medical School, Hanover, NH 03756
Communicated by Walter H. Stockmayer, November 16, 1984
ABSTRACT Conditioned medium taken from cultures of
resting rabbit synovial fibroblasts contained a protein that
prevented the synthesis of the neutral proteinase collagenase.
Conditioned medium was concentrated 10-fold and placed on
cultures of rabbit synovial fibroblasts along with an inducer of
collagenase (phorbol myristate acetate or latex particles) and
[3H]leucine. Collagenase production was measured by immu-
noprecipitation of culture medium with monospecific anti-
body. Gel filtration showed that the inhibitory factor had Mrs
of 12,500, 25,000-50,000, and 150,000, suggesting that the
protein may exist as aggregates. Activity was destroyed by
boiling, by trypsin, and by dithiothreitol. Production of the
inhibitory protein was prevented by cycloheximide. Isoelectric
focusing purified the protein 100- to 150-fold and revealed pls
in the range of 3.2-3.7. Glycosylation was demonstrated by
binding to Con A-Sepharose. Our data indicate that rabbit sy-
novial fibroblasts autoregulate collagenase production and
suggest that the low levels of collagenase seen in resting cul-
tures result from an active suppression of collagenase synthe-
sis.
The interstitial collagens are the body's most abundant
structural proteins, and collagen remodeling occurs in a
number of normal processes such as uterine resorption and
wound healing (1-3) and in diseases such as rheumatoid ar-
thritis and tumor invasion (4, 5) (for reviews, see refs. 6 and
7). The fact that collagen breakdown can be initiated only by
the metalloproteinase collagenase (EC 3.4.24.7) makes this
enzyme rate-limiting in collagenolysis and assures the impor-
tance of cellular mechanisms regulating its production. Al-
though collagenase is produced by a variety of mammalian
cell types (6, 7), the mechanisms governing collagenase syn-
thesis and secretion differ. In polymorphonuclear leuko-
cytes (8, 9) and monocytes/macrophages (10-12), collagen-
ase is synthesized and stored within the cell in granules;
secretion is regulated by factors controlling granule release
rather than by those controlling enzyme synthesis (7). In
contrast, fibroblast (e.g., skin and synovial cell) collagenase
is not stored. Addition of an inducer stimulates transcription
of collagenase mRNA followed by rapid synthesis and secre-
tion of the enzyme (13-17).
An abundant source of enzyme is that produced by fibro-
blasts derived from the synovial tissue lining the joints (4, 6,
7). Normally, these cells are quiescent, but proliferating sy-
novial tissue in rheumatoid arthritis produces large quanti-
ties of collagenase, and the role of this enzyme in the de-
struction of connective tissues is well documented (4, 6, 7).
The fact that these high levels of collagenase can be induced
by treating cultures of resting synovial fibroblasts with a va-
riety of stimuli makes these cells an attractive experimental
model for studies on mechanisms controlling collagenase
synthesis (14, 17-19).
Over the past few years, considerable information has
been obtained on the biosynthesis of synovial cell collagen-
ase. Upon addition of a stimulus to cultures of rabbit syno-
vial fibroblasts, increased collagenase mRNA is detected in
the cell by 5 hr and collagenase protein appears in the culture
medium by 10 hr (14, 17, 19). Studies on the biosynthesis of
both synovial and skin collagenase show that the time re-
quired for synthesis and secretion is <1 hr (13, 16). Synovial
cell collagenase is secreted predominantly as latent procolla-
genase ofMr 57,000, along with a small amount ofa glycosyl-
ated species of Mr 61,000 (16, 20). Activation of the latent
enzyme occurs through limited proteolysis (7) or through a
specific activator protein (7, 21) that is produced by skin,
uterine, and synovial fibroblasts.
Despite accumulated knowledge related to mechanisms of
collagenase biosynthesis, cellular events and factors that
might regulate the synthetic process and hence modulate
connective tissue metabolism are poorly understood. John-
son-Wint and Gross have indicated that this regulation may
well occur through effector molecules called cytokines (22,
23). They describe a protein produced by corneal epithelial
cells that inhibits collagenase production by corneal fibro-
blasts. In the studies described here, we report that a protein
produced by populations of rabbit synovial fibroblasts inhib-
its collagenase synthesis by these cells.
MATERIALS AND METHODS
Cell Cultures. Monolayer cultures of rabbit synovial fibro-
blasts were prepared by dissociating synovial tissue excised
from the knee joints of freshly killed New Zealand White
rabbits (Snelling Rabbitry, Springfield, VT) into a single-cell
suspension (24). Cells were plated in Dulbecco's modified
Eagle's medium (DME medium; GIBCO) in 20% fetal calf
serum (GIBCO) and gentamycin; at confluence, cells were
passaged in 10% fetal calf serum.
Preparation of Conditioned Medium and Bioassay for In-
hibitory Protein. Confluent monolayers of rabbit synovial fi-
broblasts in 100-mm-diameter culture dishes were washed
three times (5 min per wash) in Hanks' balanced salt solution
to remove traces of serum. Seven milliliters ofDME medium
supplemented with 0.2% lactalbumin hydrolysate were add-
ed, and the cultures were incubated for 48-72 hr. Before the
conditioned medium was harvested, sample portions from
each dish were tested for collagenolytic activity (18, 25). Me-
dium from cultures showing no enzyme activity in an 18-hr
assay was harvested and stored at -20°C. Medium was con-
centrated by precipitation with 80% saturated ammonium
Abbreviation: PMA, phorbol myristate acetate.
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sulfate. The precipitate was suspended in 0.05 M ammonium
bicarbonate and dialyzed exhaustively vs. this solution using
dialysis tubing with a cutoff of Mr 3500. Dialyzed material
was lyophilized.
To test the medium for biologic activity, we measured its
ability to inhibit collagenase synthesis by immunoprecipitat-
ing [3H]collagenase protein from culture medium. Lyophi-
lized samples were reconstituted 10 times concentrated in
leucine-free medium (to 1.5-2.0 mg of protein per ml), steri-
lized by filtration, and placed on confluent cultures of syno-
vial fibroblast in 35-mm-diameter culture dishes along with
an inducer of collagenase [phorbol myristate acetate (PMA)
at 10 nM; Consolidated Midland, Brewster, NY] and
[3H]leucine (6.7 Ci/mmol; 20 puCi/ml, New England Nucle-
ar, Boston; 1 Ci = 37 GBq). After 24-30 hr at 370C, cultures
were terminated by removing the medium and washing the
cells twice with cold 5% CCl3COOH. The CCl3COOH-pre-
cipitable proteins were solubilized in 1 ml of0.2 M NaOH for
determination of protein content by the method of Lowry et
al. (26).
Preparation of Antisera and Immunoprecipitation, NaDod-
SO4/PAGE, and Autoradiography. Antisera monospecific
for rabbit synovial cell collagenase and activator were pre-
pared in sheep as described by Vater et al. (21, 27). Briefly,
crude culture medium containing rabbit synovial fibroblast
collagenase was treated with sheep anti-rabbit synovial fi-
broblast collagenase antiserum, a gift of C. Vater and E. D.
Harris, Jr., in a double-immunodiffusion assay in agar. The
resulting immunoprecipitin bands were excised from the
agar, emulsified in complete Freund's adjuvant, and injected
subcutaneously into a North Country Cheviot sheep (21, 27).
Fig. 1 shows that the resultant antiserum is monospecific for
rabbit synovial cell collagenase by its single line of identity
with the antiserum known to be monospecific for this anti-
gen (21, 27) (Fig. 1 Left), by its ability to form a single band
against crude culture medium containing rabbit synovial col-
lagenase in a crossed immunoelectrophoresis assay (Fig. 1
Center), and by its ability to neutralize the activity of rabbit
synovial fibroblast collagenase (Fig. 1 Right). Antiserum to
rabbit activator was prepared in an identical manner and was
shown to be monospecific by the same criteria (21).
Synthesis of immunoreactive collagenase was detected in
culture medium as described previously (16).
Gel Filtration. Concentrated conditioned medium was ap-
plied to Ultrogel AcA 44 or AcA 54 equilibrated in phos-
phate-buffered saline containing either 0.15 M or 1 M NaCl.
Fractions (2 ml) were collected at 12 ml/hr, and absorbance
at 280 nm was determined. Fractions were pooled in groups
of three, dialyzed vs. 0.05 M ammonium bicarbonate, lyoph-
ilized, resuspended in 2 ml of leucine-free medium with
[3H]leucine, and assayed for their ability to inhibit collagen-
ase synthesis.
Isoelectric Focusing and Con A-Sepharose Chromatogra-
phy. Concentrated culture medium was dialyzed vs. 0.05 M
ammonium bicarbonate and lyophilized. Lyophilized materi-
al, containing =20 mg of protein, was suspended in a small
volume of water and subjected to isoelectric focusing (21).
Appropriate fractions isolated from the isoelectric focus-
ing column pH 2.5-4 were pooled, and subjected to Con A-
Sepharose chromatography as described in ref. 21.
Materials. Trypsin, soybean trypsin, inhibitor, dithiothrei-
tol, and cycloheximide were purchased from Sigma. Latex
particles were from Difco.
RESULTS
Inhibition of Collagenase Synthesis by Conditioned Medi-
um. Fig. 2 shows that when 10-times-concentrated condi-
tioned medium was placed on cultures of fibroblasts, colla-
genase production was inhibited. In Fig. 2A, lanes 1 and 2
represent the negative control of immunoprecipitable colla-
genase synthesized by cells treated with nonconditioned me-
dium. Lanes 3 and 4 represent the positive control of collagen-
ase synthesized by cells treated with nonconditioned medi-
um in the presence of the collagenase inducer PMA. Lanes 5
and 6 show collagenase produced by cells treated with x 10
conditioned medium and PMA. Compared with the positive
control, there is less collagenase synthesized by cultures
treated with the conditioned medium. Fig. 2B shows that the
pattern of proteins synthesized and secreted by all groups of
cells is similar, demonstrating that the decrease in collagen-
ase production is not the result of a generalized toxic effect
on protein synthesis. In support of this idea, the protein con-
tent of the control and experimental cultures is indistinguish-
able (1049 ± 117 ,ug).
The suppressive effect of conditioned medium was quanti-
fied in three experiments (Table 1). In all experiments, treat-
ment with nonconditioned medium and PMA elevated colla-
genase well above control cultures, and treatment with con-
ditioned medium antagonized the effect of PMA by reducing
collagenase levels nearly to those of the control cultures. To










FIG. 1. Characterization of monospecific antibody to rabbit synovial fibroblast collagenase. Sheep anti-rabbit synovial fibroblast collagen-
ase antiserum was prepared and tested for monospecificity as described in Materials and Methods and in refs. 21 and 27. Antiserum was tested
for monospecificity by double immunodiffusiwnassay (Left), by crossed immunoelectrophoresis (Center), and by neutralization of collagenase
activity (Right). (Left) Wells: 1, reference standard of sheep antirabbit synovial fibroblast collagenase antiserum (21, 27); 2, our preparation of
sheep anti-rabbit synovial fibroblast collagenase antiserum; 3, 20-times-concentrated crude culture medium from PMA-stimulated cells. (Cen-
ter) Thirty microliters of crude (x20) concentrated culture medium from PMA-stimulated rabbit synovial fibroblasts was electrophoresed in 1%
agarose at pH 8.6. Separated antigens were then electrophoresed for the second dimension into agarose containing our antiserum to rabbit
synovial fibroblast collagenase. (Right) Culture medium from PMA-stimulated rabbit synovial fibroblasts was activated with trypsin (21, 27).
Samples of activated culture medium were mixed with various dilutions of our preparation of sheep anti-rabbit synovial fibroblast collagenase
IgG (undiluted = 2.3 mg of protein per ml) or with undiluted nonimmune IgG (2.7 mg of protein per ml) for 1 hr at 37°C and then overnight at
4°C. Reaction mixtures were centrifuged, and the supernatants were assayed for collagenase activity in a 7-hr assay with fibrils of radiolabeled
collagen substrate (21, 27).
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FIG. 2. Inhibition of collagenase synthesis by conditioned medi-
um. Duplicate cultures of rabbit synovial fibroblasts were treated
with 10-times-concentrated conditioned medium, prepared as de-
scribed, PMA (10 nM) and [3H]leucine. Duplicates of control cul-
tures received nonconditioned medium without PMA (negative con-
trol) or with it (positive control) and [PH]leucine. After 30 hr at 37TC,
synthesis of [3H]collagenase was measured by immunoprecipitation
(A), and the pattern of culture medium proteins was visualized (B)
by gel electrophoresis and autoradiography. Lanes: 1, 2, 7, and 8,
nonconditioned medium; 3, 4, 9, and 10, nonconditioned medium
with PMA; 5, 6, 11, and 12, x 10 conditioned medium with PMA.
tioned medium on the PMA, we tested the ability of condi-
tioned medium to inhibit induction by latex beads (100
,g/ml) (28). In this experiment, treatment with PMA or latex
induced 555 ± 87 or 286 ± 13 cpm of immunoprecipitable
collagenase, respectively. Concomitant treatment with PMA
and x 10 conditioned medium or with latex and x 10 condi-
tioned medium reduced the cpm of immunoprecipitable col-
lagenase to 122 ± 16 for PMA and to 47 ± 4 for latex.
To show that resting cultures were actively synthesizing
and secreting the inhibitory factor, we treated cell cultures
with cycloheximide at 5 ,g/ml for 48 hr. This medium was
harvested, processed as described earlier, and placed on
cells for its ability to inhibit collagenase synthesis in the
presence of PMA. Table 2 shows that conditioned medium
from cycloheximide-treated cultures failed to inhibit induc-
tion of collagenase synthesis. The cycloheximide treatment
was not toxic to cells producing the conditioned medium:
levels of lactate dehydrogenase in the culture medium were
not elevated, and the protein content of the cycloheximide-
treated cultures was 75% of control cultures.
Determination of Molecular Weight and Characterization.
The molecular weight of the inhibitory factor was deter-
mined by fractionating conditioned medium on Ultrogel AcA
Table 1. Quantitation of the inhibition of collagenase synthesis
by conditioned medium (CM)
[3H]Collagenase, cpm
Treatment of cells Exp. I Exp. II Exp. III
xl non-CM 375 ± 19 321 ± 38 566 ± 130
xl non-CM with PMA 3152 ± 93 920 ± 51 934 ± 50
xlOCM with PMA 766 ± 134 609 ± 44 297 ± 94
In three experiments, duplicate cultures were treated with 10-
times-concentrated conditioned medium, prepared as described,
along with PMA (10 nM) and [3H]leucine. Control cultures received
nonconditioned medium (non-CM), with or without PMA, and
[3H]leucine. Cultures were incubated and assayed as described in
Fig. 1, and the amount of immunoprecipitable [3H]collagenase was
quantified. Data are means ± SD.
Table 2. Effect of cycloheximide on the synthesis of
inhibitory protein
Treatment of cells [3H]Collagenase, cpm
x 1 non-CM 150
x 1 non-CM with PMA 485
x 10 CM with PMA 103
x 10 CM (cycloheximide-treated cells)
with PMA 627
Ten-times-concentrated conditioned medium was prepared from
parallel cultures that were or were not treated for 48 hr with
cycloheximide (5 gg/ml). The medium was assayed for its ability to
inhibit the synthesis of [3H]collagenase. [3H]Collagenase was im-
munoprecipitated from culture medium and quantified.
44 in physiologic saline. Fractions were pooled in groups of
three, dialyzed, lyophilized, and reconstituted in leucine-
free medium with [3H]leucine and PMA and were assayed
for their ability to inhibit induction of collagenase synthesis.
Fig. 3 Left shows that fractions containing protein with Mr
150,000, 25,000, and 12,500 contained inhibitory activity. A
second experiment with Ultrogel AcA 54 and 1 M salt (Fig. 3
Right) confirmed the presence of inhibitory activity at sever-
al areas across the column. Similar to the data shown in Fig.
3 Left activity was seen at Mr 150,000 and 12,500, but in this
experiment inhibition occurred predominantly at Mr 50,000
rather than at Mr 25,000, suggesting the possible existence of
aggregated protein.
We further characterized this inhibitory protein by sub-
jecting it to a variety of experimental conditions. Inhibitory
activity of the x 10 conditioned medium was destroyed by
boiling for 10 min, by trypsin (100 pug/ml for 60 min at RT,
followed by addition of soybean trypsin inhibitor) or by 10
mM dithiothreitol (for 30 min). Addition of trypsin and soy-
bean trypsin inhibitor to cultures in the absence of PMA
failed to induce collagenase, thus indicating that the pres-
ence of large amounts of these proteins could not stimulate
collagenase synthesis (data not shown).
Isoelectric Focusing and Con A-Sepharose Chromatogra-
phy. Initial experiments used an isoelectric focusing column
and ampholytes with the pH range of 6-8, with extreme pH
gradients seen at each end of the column. Fractions from the
column were pooled in groups of five and were assayed for
their ability to inhibit collagenase production. Fig. 4 Upper
shows that fractions containing protein with pIs in the range
of 3-5 inhibited induction of collagenase.
Since activator protein is important in the regulation of
enzymatically active collagenase (7, 21) and since both colla-
genase and activator are found in medium from induced cul-
ture (21), we tested whether the material preventing collagen-
nase synthesis could also diminish production of activator.
Fig. 4 Lower shows (i) that the same fractions capable of
inhibiting collagenase production also prevent production of
activator and (ii) that the inhibitory activity was destroyed
by boiling. Fractions taken from other areas of the column
did not affect activator synthesis (data not shown).
Isoelectric focusing with ampholytes in the range of pH
2.5-4 was used to further fractionate the inhibitory protein
(Fig. 5 Upper). In three experiments, major areas of inhibi-
tory activity focused in the range of pI 3.2-3.7 and were puri-
fied at least 100- to 150-fold.
The variation in pI could indicate heterogeneity in glyco-
sylation. To demonstrate glycosylation, we measured the
ability of the inhibitory fractions to bind to Con A-Sepharose
(Fig. 5 Lower). The figure shows that cells treated with non-
inhibitory fractions produced large amounts of collagenase
and that most of the activity in the inhibitory fraction bound
to Con A. However, some inhibitory material did not bind,
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FIG. 3. Gel filtration of protein inhibiting col-
lagenase synthesis. Conditioned medium was
concentrated, dialyzed, lyophilized, and resus-
pended in phosphate-buffered saline containing
NaCl at 0.15 M (Left) or 1 M (Right) and passed
through Ultrogel AcA 44 (Left) or AcA 54
(Right). Fractions were pooled in groups of three,
dialyzed, lyophilized, and reconstituted in leu-
cine-free medium with [3H]leucine and assayed
for their ability to inhibit the induction of [3H]col-
lagenase in the presence of PMA (10 nM). [3H]-
Collagenase was immunoprecipitated from cul-
ture medium and quantified.
DISCUSSION
In this paper, we describe a protein that is synthesized and
secreted by rabbit synovial cells and that inhibits the produc-
tion of both collagenase and its activator by these cells. It is
an autoregulatory protein in the sense that it is a protein pro-
duced by mesenchymal cells and that acts on these same
cells. In the absence of cloned populations of synovial fibro-
blasts, it is impossible to determine whether or not the in-























al fibroblasts and acts to prevent collagenase synthesis by
another subset. The protein appears not to be stored, since



















FIG. 4. Isoelectric focusing of protein inhibiting synthesis of col-
lagenase and activator. (Upper) Inhibition of collagenase synthesis.
Conditioned medium (containing -20 mg of protein) that had been
dialyzed and concentrated was applied to an isoelectric focusing col-
umn with ampholytes in the pH range of 6-8. Fractions (1 ml) were
collected, pooled in groups of five, and assayed by immunoprecip-
itation for their ability to inhibit synthesis of [3H]collagenase in the
presence of PMA (10 nM). (Lower) Inhibition of collagenase and
activator synthesis and effect of boiling on inhibitory activity. The
two fractions containing inhibitory activity were pooled. Each pool
was divided in half: one-half was boiled for 10 min, and the other
half was sham-treated. After dialysis vs. leucine-free medium, the
fractions were placed on virgin fibroblasts, and medium from these
cultures was assayed by immunoprecipitation for the amount of
[3H]collagenase and [3H]activator synthesized.
FIG. 5. Isoelectric focusing of protein inhibiting collagenase syn-
thesis. (Upper) Inhibition of collagenase synthesis. Conditioned me-
dium (containing -20 mg of protein) that had been dialyzed and con-
centrated was applied to an isoelectric focusing column with ampho-
lytes in the pH range of 2.5-4. Fractions (1 ml) were collected,
pooled in groups of five, and assayed by immunoprecipitation for
their ability to inhibit the synthesis of [3H]collagenase in the pres-
ence ofPMA (10 nM). (Lower) Binding of inhibitory protein to Con
A-Sepharose. Three fractions containing inhibitory activity were
pooled, as were three adjacent noninhibitory fractions. Each pool
was passed through a Con A-Sepharose column equilibrated with 50
mM Tris, pH 8.0/0.15 M NaCl, and bound material was eluted with
0.5 M a-methylmannoside. After dialysis and lyophilization, bound
and unbound fractions, each containing 150 pg of protein, were test-
ed for their ability to inhibit the synthesis of [3H]collagenase in the
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by boiling, by trypsin, and by dithiothreitol. It has apparent
Mrs of 12,500, 25,000-50,000, and 150,000 and may exist as
aggregates. Partial purification was achieved by isoelectric
focusing and Con A-Sepharose chromatography. The rela-
tively low pI of this protein (3.2-3.7) suggests that it may be
heavily glycosylated, and this was confirmed by affinity
chromatography with Con A-Sepharose. The broad range
over which this inhibitory protein focused indicates hetero-
geneity in glycosylation, as is known to occur in a number of
proteins, such as immune interferon (29), synovial cell colla-
genase (16), and interleukin 2 (30).
In our system, the inhibitory protein acts as an autoregu-
latory protein, actively maintaining a constitutive level of
collagenase synthesis by resting cultures. This concept of an
active suppression of collagenase production contrasts with
the supposition that the absence of collagenase in resting cul-
tures correlated with the absence of a stimulus (7, 18) and
was therefore a "passive" phenomenon. To date, most stud-
ies on the regulation of collagenolysis have been concerned
with compounds that modulate collagenase activity (6, 7)
rather than synthesis. These include proteases such as plas-
min (31), trypsin (32, 33), kallikrein (34), and, more recently,
activator (21) that activate the latent enzyme. Conversely,
there are numerous and nearly ubiquitous specific and non-
specific protease inhibitors of active collagenase (7). These
include a2-macroglobulin (35, 36), ovostatin (37, 38), and a
specific inhibitor of metalloproteinases that is produced by
skin (39), lung, corneal, and tendon fibroblasts as well as by
osteoblasts and smooth muscle cells (40). It is probably iden-
tical to the P1 anti-collagenase inhibitor found in serum (7,
40), and its abundance suggests that it may be an important
mechanism for regulating the activity of metalloproteinases
in connective tissues throughout the body (7, 40).
A protein acting at a level other than the proteolysis-based
mechanism and capable of regulating the actual synthesis of
collagenase has important implications for connective tissue
biology and pathology. The previous description of an inhibi-
tory protein capable of controlling production of corneal col-
lagenase (22, 23) and our description here of a similar factor
operative in the control of the synthesis of synovial cell col-
lagenase suggest that, similar to the inhibitor of metallopro-
teinase activity, this type of regulatory protein may be fairly
widespread throughout the body. This suggestion receives
support from the fact that collagenase produced by synovial
and skin fibroblasts share a variety of biochemical and bio-
logical characteristics. Both exist in doublet form (13-17, 41,
42) and are rapidly synthesized and secreted (13, 16), and,
most importantly, synthesis of both can be regulated by the
same growth factors and hormones (7, 18, 43-45).
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